About the Company
precigen, inc. discovers and develops the next generation of gene and cellular therapies in the united states. it also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; proprietary methane bioconversion platform that turns natural gas into energy and chemical products; and reproductive and embryo transfer technologies. in addition, the company offers ultravector platform that incorporates advanced dna construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbil15, a gene that enhances functional characteristics of immune cells; sleeping beauty, a non-viral transposon/transposase system; attsite recombinases, which breaks and rejoins dna at specific sequences; adenoverse technology platform, a library of engineered adenovector serotypes; and l. lactis is a food-grade bacterium. additionally, it provides rheoswitch inducible gene switch that provides qua
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
106
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PGEN News
Precigen, Inc.'s (NASDAQ:PGEN) top owners are private equity firms with 38% stake, while 30% is held by institutions
Key Insights Precigen's significant private equity firms ownership suggests that the key decisions are influenced ...
Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th
Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the Company will ...
Precigen files patent for insect population control using multiple lethal gene expression systems
Discover how Precigen Inc.'s patented method uses lethal gene expression systems to revolutionize insect population control. Learn more about this innovative approach now!
Stocks Settle Higher on Strength in Megacap Tech Stocks
Monday closed up +0.63%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.20%, and the Nasdaq 100 Index ($IUXX) ...
PTC Therapeutics files patent for pharmaceutical composition for treating various diseases
Discover the innovative pharmaceutical composition patented by PTC Therapeutics Inc. to treat diseases like a-synucleinpathy and liver diseases. Learn about the specific ratios of ingredients and ...
Earnings week ahead: FedEx, Nike, XPeng, Tencent, General Mills and more
StoneCo (STNE), a provider of financial technology and software solutions, is scheduled to report its Q4 earnings after ...
Loading the latest forecasts...